Related Stories143 Million People May Soon Become Climate Migrants

Media coverage about Crispr Therapeutics (NASDAQ:CRSP) has been trending somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to […]

Shares of Spark Therap (ONCE) are moving on volatility today -7.69% or $-5.19 from the open. The NASDAQ listed company saw a recent bid of $62.32 and 484771 shares have traded hands in the session. Investors have the ability to approach the stock market from various angles. This may include using technical analysis, fundamental analysis, or a combination or the two. Investors watching […]

Morgens Waterfall Vintiadis & Co. Inc. purchased a new position in shares of Crispr Therapeutics AG (NASDAQ:CRSP) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 30,000 shares of the company’s stock, valued at approximately $704,000. Morgens Waterfall Vintiadis & Co. Inc. owned approximately 0.07% […]

The shares of Top Ships Inc. have decreased by more than -25.50% this year alone. The shares recently went up by 2.63% or $0.01 and now trades at $0.19. The shares of CRISPR Therapeutics AG (NASDAQ:CRSP), has jumped by 120.49% year to date as of 03/16/2018. The shares currently trade at $51.77 and have been […]

Crispr Therapeutics AG (NASDAQ:CRSP) is one of the hottest biotech names in the market today. After going sideways for much of last year, Crispr stock surged to a massive 106% performance year-to-date. Obviously, CRSP has momentum on its side, but can this ridiculous rally continue forward? At this juncture, CRSP stock is a pure, speculative […]

19 March 2018 Appeared in BioNews 942 Researchers in the USA have developed a new RNA editing approach, which could be beneficial in treating dementia. The new approach is similar to CRISPR/Cas9, which can cut and modify DNA at precise locations, but the enzyme, Cas9, is replaced with one which edits RNA rather than DNA.  […]

Headlines about Crispr Therapeutics (NASDAQ:CRSP) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with […]

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) closed the previous trading session at $51.77, experiencing a change of -1.58% with 1,111,128 shares trading hands. The stock holds an average trading capacity of 1.05M shares for the past three months. When we compare its current volume with average for the same time of day, a Relative Volume […]

A team from the Salk Institute has created a new gene-editing tool that targets RNA and could correct a protein imbalance in the cells of dementia patients, restoring them to healthy levels. CRISPR/Cas9 gene-editing technology has traditionally targeted DNA, acting as molecular scissors to cut and replace disease-causing genes with healthy ones. The new tool, […]